Results 101 to 110 of about 121,674 (149)

Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. [PDF]

J Immunother Cancer
Minnee J, Wong WZ, Russell BS, Semana JL, Li R, Landau NR, Tada T.   +6 more
europepmc   +1 more source

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications. [PDF]

Leukemia
Schadt J, von Bonin M, Oelschlägel U, Teipel R, Epp K, Saalfeld FC, Schulze F, Heuschkel S, Bornhäuser M, Röhnert MA.   +9 more
europepmc   +1 more source

Microfluidic perspectives on chimeric antigen receptor T-cell migration in solid tumours: highlighting physical confinement as a key barrier.

Mol Syst Des Eng
Gonzalez Abrego V, Chin MHW, Coppens MO.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chimeric antigen receptors

Nature Biotechnology, 2022
openaire   +2 more sources

Chimeric antigen receptors

Nature Biotechnology, 2020
openaire   +2 more sources

CHIMERIC ANTIGEN RECEPTOR

2022
MENG KEVIN P, MURAKAMI JODI, HAILE SAMUEL T, LIAO EDWARD H   +3 more
openaire   +5 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Boll, Elie Azoulay   +2 more
exaly  

Chimeric Antigen Receptor beyond CAR-T Cells

Cancers, 2021
Paul Neeson, Criselle Dsouza, Joe Zhu
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Kennedy
exaly